Literature DB >> 12600422

The value of corpus cavernosum electromyography in erectile dysfunction: current status and future prospect.

X G Jiang1, T G W Speel, G Wagner, E J H Meuleman, H Wijkstra.   

Abstract

In the last decade, several investigators have tried to develop corpus cavernosum electromyography (CC-EMG) as a direct clinical method to evaluate the state of the penile autonomic innervation and the cavernous smooth muscle. Both basic and clinical studies have shown promising results. However, its application as a diagnostic tool with clinical relevance was hindered by insufficient knowledge of cavernous smooth muscle electrophysiology, lack of standardization, technical and practical difficulties and problems in the interpretation of the results. Recently, the European Commission created the so-called COST Action B18 (corpus cavernosum EMG in erectile dysfunction), aiming to strengthen the coordination of the European research groups and give the development of CC-EMG a new impetus. This review presents an overview of the physiological background, the current status of CC-EMG, and discusses possibilities for further developments. Copyright 2003 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2003        PMID: 12600422     DOI: 10.1016/s0302-2838(03)00011-3

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Evoked cavernous activity: normal values.

Authors:  Claire C Yang; Ugur Yilmaz; Brenda G Vicars
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

2.  Modulation of spontaneous Ca2+-activated Cl- currents in the rabbit corpus cavernosum by the nitric oxide-cGMP pathway.

Authors:  M Craven; G P Sergeant; M A Hollywood; N G McHale; K D Thornbury
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

Review 3.  Clinical autonomic neurophysiology and the male sexual response: an overview.

Authors:  Claire C Yang; Xiaogang Jiang
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.